Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Patients With Persistent Proteinuria on Long-Term ACEI Therapy
NCT00106561Phase 3Completed
- Sponsor
- Melbourne Health
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of spironolactone in proteinuria, sponsored by Melbourne Health. Started Jan 2002; status: completed.
02
Drugs
spironolactone
03
Conditions
proteinuria
Beyond the preview
Go deeper on NCT00106561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106561.